Live Audio Webcast Thursday, September 25, 2008
SAN DIEGO, Sept. 22 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc.
(Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief
Executive Officer of Neurocrine Biosciences will be presenting at the UBS
Global Life Sciences Conference at the Grand Hyatt in New York.
The live presentation takes place Thursday, September 25, 2008 at
10:00 a.m. Eastern Time (ET) /7:00 a.m. Pacific Time (PT). The presentation
will be simultaneously webcast and may be accessed on the Company's website at
http://www.neurocrine.com which will link you to the UBS Conference site.
Once you have been linked to their site, you have the option to search by
company name, or by time and date to access the webcast.
If you are unable to attend the webcast and would like further information
on this announcement please contact the Investor Relations Department at
Neurocrine Biosciences at (858) 617-7600. Viewers are encouraged to visit the
website approximately 5 minutes prior to the presentation to download or
install any necessary software. A replay of the presentation will be available
approximately three hours after the conclusion of the live event and will be
archived on the website for two weeks.
About Neurocrine
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on
neurological and endocrine diseases and disorders. Our product candidates
address some of the largest pharmaceutical markets in the world including
endometriosis, irritable bowel syndrome (IBS), anxiety, depression, pain,
diabetes, benign prostatic hyperplasia (BPH) and other neurological and
endocrine related diseases and disorders. Neurocrine Biosciences, Inc. news
releases are available through the Company's website via the internet at
http://www.neurocrine.com
SOURCE Neurocrine Biosciences, Inc.
